PCBD1 Gene (Pterin-4-Alpha-Carbinolamine Dehydratase)

PCBD1 Gene - Pterin-4-Alpha-Carbinolamine Dehydratase

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PCBD1 Gene (Pterin-4-Alpha-Carbinolamine Dehydratase)</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PCBD1</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Pterin-4-Alpha-Carbinolamine Dehydratase</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>PCD, DCOH, PTPS</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>10q22.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>51133</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>264070</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000156030</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y5Q1</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>103 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~11.5 kDa</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Highest in liver, brain (cortex, cerebellum)</td>
</tr>
<tr>
<td class="label">Disorder</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Dopamine deficiency</td>
<td>Impaired TH activity</td>
</tr>
<tr>
<td class="label">Serotonin deficiency</td>
<td>Impaired TPH activity</td>
</tr>
<tr>
<td class="label">Phenylalanine elevation</td>
<td>Impaired PAH activity</td>
</tr>
<tr>
<td class="label">NO deficiency</td>
<td>Impaired NOS activity</td>
</tr>
<tr>

PCBD1 Gene - Pterin-4-Alpha-Carbinolamine Dehydratase

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PCBD1 Gene (Pterin-4-Alpha-Carbinolamine Dehydratase)</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PCBD1</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Pterin-4-Alpha-Carbinolamine Dehydratase</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>PCD, DCOH, PTPS</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>10q22.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>51133</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>264070</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000156030</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y5Q1</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>103 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~11.5 kDa</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Highest in liver, brain (cortex, cerebellum)</td>
</tr>
<tr>
<td class="label">Disorder</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Dopamine deficiency</td>
<td>Impaired TH activity</td>
</tr>
<tr>
<td class="label">Serotonin deficiency</td>
<td>Impaired TPH activity</td>
</tr>
<tr>
<td class="label">Phenylalanine elevation</td>
<td>Impaired PAH activity</td>
</tr>
<tr>
<td class="label">NO deficiency</td>
<td>Impaired NOS activity</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">Brain (cortex)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Brain (cerebellum)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Low-moderate</td>
</tr>
<tr>
<td class="label">Lung</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">PCBD1 activity</td>
<td>Enzyme activators</td>
</tr>
<tr>
<td class="label">BH4 metabolism</td>
<td>Pathway modulators</td>
</tr>
<tr>
<td class="label">Neurotransmitter synthesis</td>
<td>Precursor loading</td>
</tr>
<tr>
<td class="label">Oxidative stress</td>
<td>Antioxidants</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Overview

PCBD1 (Pterin-4-Alpha-Carbinolamine Dehydratase), also known as pterin-4-carbinolamine dehydratase or dihydropteridine dehydratase, is a key enzyme in the tetrahydrobiopterin (BH4) biosynthesis and regeneration pathway. BH4 is an essential cofactor for several critical enzymatic reactions, including the synthesis of the neurotransmitters dopamine and serotonin, the metabolism of phenylalanine, and the production of nitric oxide. [@hauer2015]

Located on chromosome 10q22.1, PCBD1 is expressed in various tissues, with particularly high levels in the liver and brain. The enzyme catalyzes the dehydration of 4-alpha-hydroxy-tetrahydropterin to quinonoid dihydrobiopterin (qBH2), a crucial step in the recycling of BH4 from its oxidized form. This regeneration process is essential for maintaining adequate BH4 levels, as the cofactor is continuously oxidized during its role as an electron donor in enzymatic reactions. [@citino1992]

PCBD1 deficiency leads to impaired BH4 recycling, resulting in secondary BH4 deficiency. This condition manifests with neurological symptoms including movement disorders, developmental delay, and neurotransmitter deficiencies. Beyond its well-characterized role in phenylketonuria (PKU) and related disorders, PCBD1 dysfunction has been implicated in neurodegenerative diseases including Parkinson's disease (PD) and Alzheimer's disease (AD), where BH4 metabolism is perturbed. [@nixon2005]

Gene Information

Protein Structure and Function

PCBD1 is a small enzyme with a distinctive structure:

Structural Features

Homodimer Formation:

• Functions as a homodimer
• Each subunit is approximately 11.5 kDa
• Dimerization is required for full enzymatic activity
• Forms a stable quaternary structure

• Requires zinc for structural stability
• Zn2+ ions coordinate at the active site
• Essential for proper folding
• Loss of zinc leads to enzyme inactivation

• Contains the catalytic dehydratase activity
• Binds pterin substrates
• Catalyzes dehydration reaction
• Requires BH4-related substrates

Enzymatic Activity

The enzymatic function of PCBD1 involves:

Reaction Catalyzed:

4-α-Hydroxy-tetrahydropterin → Quinonoid dihydrobiopterin + H2O

This reaction converts the oxidized form of BH4 back to the active qBH2, which can then be further reduced to BH4 by dihydropteridine reductase (DHPR).

Role in Tetrahydrobiopterin Metabolism

BH4 Biosynthesis Pathway

PCBD1 participates in the BH4 regeneration cycle:

De Novo Synthesis:

• GTP is the starting point
• Multiple enzymes involved (GCH1, PTS, QDPR)
• Rate-limiting step: GTP cyclohydrolase I (GCH1)

• PCBD1 functions in the salvage pathway
• Recycles oxidized BH4 derivatives
• Works with DHPR to regenerate BH4
• Critical for maintaining BH4 pools

BH4 as Cofactor

BH4 serves as a critical cofactor for multiple enzymes:

Phenylalanine Hydroxylase (PAH):

• Converts phenylalanine to tyrosine
• BH4 is essential cofactor
• Defects lead to phenylketonuria

• Rate-limiting step in dopamine synthesis
• Converts tyrosine to L-DOPA
• BH4 required for activity

• Rate-limiting step in serotonin synthesis
• Converts tryptophan to 5-HTP
• BH4 required for activity

• eNOS, nNOS, iNOS all require BH4
• NO production depends on BH4
• Important for vascular function

Role in Neurodegeneration

Parkinson's Disease (PD)

PCBD1 and BH4 metabolism are implicated in PD:

Dopamine Synthesis

Nixon et al. (2005) investigated BH4 in PD:

• BH4 is essential for tyrosine hydroxylase activity
• Dopamine synthesis depends on adequate BH4
• PD patients show altered BH4 metabolism
• Therapeutic implications

Oxidative Stress

Werner-Felmayer et al. (2002) explored BH4 in oxidative stress:

• BH4 is a potent antioxidant
• Protects against oxidative damage
• BH4 deficiency increases vulnerability
• Links to PD pathogenesis

Neuroprotective Potential

Neumann et al. (2015) explored BH4 therapy:

• BH4 supplementation explored in PD models
• Protective effects on dopaminergic neurons
• Improved neurotransmitter function
• Clinical trials ongoing

Alzheimer's Disease (AD)

PCBD1 contributes to AD pathogenesis:

Neurotransmitter Dysfunction

He et al. (2013) investigated BH4 in AD:

• Altered BH4 levels in AD brain
• Affects acetylcholine synthesis
• Contributes to cognitive dysfunction
• Links to cholinergic deficit

Protein Homeostasis

Lepp et al. (2018) explored BH4 and proteostasis:

• BH4 affects protein folding
• Impaired BH4 increases aggregation
• Links to amyloid pathology
• Therapeutic targeting potential

Synaptic Function

Yang et al. (2016) characterized PCBD1 in brain:

• Expressed in neurons and glia
• Required for synaptic function
• Affects neurotransmitter levels
• Changes in AD models

Movement Disorders

PCBD1 deficiency causes neurological symptoms:

Pediatric Disorders

Kurian et al. (2011) characterized BH4 deficiency:

• Severe movement disorders
• Developmental delay
• Hypotonia
• Dystonia

Adult-Onset

Swoboda et al. (2012) explored BH4 in adults:

• Adult-onset movement disorders
• Gait disturbances
• Tremor
• Dystonia

Disease Associations

Primary BH4 Deficiency (via PCBD1)

Mutations in PCBD1 can cause BH4 deficiency:

Chaves et al. (2009) identified PCBD1 mutations:

• Autosomal recessive inheritance
• Variable phenotype
• May be mild or severe
• Responds to BH4 supplementation

• Phenylalanine elevation
• Neurotransmitter deficiencies
• Variable penetrance
• Treatment available

Phenylketonuria (PKU)

While PCBD1 doesn't cause classic PKU:

• Secondary BH4 deficiency can mimic PKU
• Similar neurological symptoms
• Requires differential diagnosis
• Treatment with BH4 may help

Neurotransmitter Disorders

PCBD1 dysfunction leads to:

Expression Pattern

PCBD1 exhibits tissue-specific expression:

In the brain, PCBD1 is expressed in:

• [Neurons](/cell-types/neurons): Throughout cortex and cerebellum
• [Astrocytes](/cell-types/astrocytes): Supporting neuronal function
• [Microglia](/cell-types/microglia-neuroinflammation): Resident immune cells

Therapeutic Implications

BH4 Supplementation

BH4 therapy has been explored:

• Oral BH4 can bypass metabolic blocks
• Improves neurotransmitter synthesis
• May slow disease progression
• Used in PKU and related disorders

Gene Therapy Approaches

• AAV-mediated PCBD1 delivery
• RNA-based therapeutics
• Combination approaches

Small Molecule Modulators

Research Directions

Current research focuses on:

Summary

PCBD1 (Pterin-4-Alpha-Carbinolamine Dehydratase) is an essential enzyme in the tetrahydrobiopterin (BH4) regeneration pathway. Located on chromosome 10q22.1, PCBD1 catalyzes the conversion of 4-alpha-hydroxy-tetrahydropterin to quinonoid dihydrobiopterin, a crucial step in recycling oxidized BH4.

BH4 is an essential cofactor for phenylalanine hydroxylase, tyrosine hydroxylase, tryptophan hydroxylase, and nitric oxide synthases. Impaired PCBD1 function leads to BH4 deficiency, causing neurological symptoms including movement disorders, developmental delay, and neurotransmitter deficiencies.

In neurodegenerative diseases, altered BH4 metabolism contributes to dopaminergic dysfunction in Parkinson's disease, neurotransmitter deficits in Alzheimer's disease, and oxidative stress in both conditions. Understanding PCBD1's role provides opportunities for therapeutic targeting of the BH4 pathway in these conditions.

See Also

• [Tetrahydrobiopterin Pathway](/mechanisms/bh4-pathway)
• [Dopamine Biosynthesis](/mechanisms/dopamine-biosynthesis)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Phenylketonuria](/diseases/phenylketonuria)
• [Neurotransmitter Disorders](/diseases/neurotransmitter-disorders)
• [Oxidative Stress](/mechanisms/oxidative-stress)

External Links

• [NCBI Gene: PCBD1](https://www.ncbi.nlm.nih.gov/gene/51133)
• [UniProt: Q9Y5Q1](https://www.uniprot.org/uniprotkb/Q9Y5Q1/entry)
• [GeneCards: PCBD1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PCBD1)
• [OMIM: 264070](https://www.omim.org/entry/264070)
• [Ensembl: ENSG00000156030](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000156030)

References